Prostate cancer: brachytherapy linked to small risk for bladder cancer

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Takeaway
  • The incidence of a second primary cancer (SPC) after low-dose brachytherapy (BT) for prostate cancer is low, but there may be a small increase in the risk for subsequent bladder cancer.
Study design
  • The study included 889 patients with early prostate cancer who were treated at both privat...